Neuronal cell death in nervous system development, disease, and injury (Review)

被引:1
|
作者
Martin, LJ [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Neuropathol & Neurosci, Dept Pathol, Baltimore, MD 21205 USA
关键词
Alzheimer's disease; amyotrophic lateral sclerosis; cell death; cerebral ischemia; motor neuron degeneration; stroke; traumatic brain injury; apoptosis-necrosis continuum;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neuronal death is normal during nervous system development but is abnormal in brain and spinal cord disease and injury. Apoptosis and necrosis are types of cell death. They are generally considered to be distinct forms of cell death. The re-emergence of apoptosis may contribute to the neuronal degeneration in chronic neurodegenerative disease, such as amyotrophic lateral sclerosis and Alzheimer's disease, and in neurological injury such as cerebral ischemia and trauma. There is also mounting evidence supporting an apoptosis-necrosis cell death continuum. In this continuum, neuronal death can result from varying contributions of coexisting apoptotic and necrotic mechanisms; thus, some of the distinctions between apoptosis and necrosis are becoming blurred. Cell culture and animal model systems are revealing the mechanisms of cell death. Necrosis can result from acute oxidative stress. Apoptosis can be induced by cell surface receptor engagement, growth factor withdrawal, and DNA damage. Several families of proteins and specific biochemical signal-transduction pathways regulate cell death. Cell death signaling can involve plasma membrane death receptors, mitochondrial death proteins, proteases, kinases, and transcription factors. Players in the cell death and cell survival orchestra include Pas receptor, Bcl-2 and Bar (and their homologues), cytochrome c, caspases, p53, and extracellular signal-regulated protein kinases. Some forms of cell death require gene activation, RNA synthesis, and protein synthesis, whereas others forms are transcriptionally-translationally-independent and are driven by posttranslational mechanisms such as protein phosphorylation and protein translocation. A better understanding of the molecular mechanisms of neuronal cell death in nervous system development, injury and disease can lead to new therapeutic approaches for the prevention of neurodegeneration and neurological disabilities and will expand the field of cell death biology.
引用
收藏
页码:455 / 478
页数:24
相关论文
共 50 条
  • [41] Editorial: Non-neuronal cell heterogeneity in the nervous system during health and disease
    Duncan, Greg J.
    Assinck, Peggy
    Stratton, Jo Anne
    Ajami, Bahareh
    Plemel, Jason R.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [42] Cell Injury and Death: Oxidative Stress and Antioxidant Defense System: Review
    Esrefoglu, Mukaddes
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2009, 29 (06): : 1660 - 1676
  • [43] CYTOKINES IN THE CENTRAL-NERVOUS-SYSTEM - REGULATORY ROLES IN NEURONAL FUNCTION, CELL-DEATH AND REPAIR
    SEI, Y
    VITKOVIC, L
    YOKOYAMA, MM
    NEUROIMMUNOMODULATION, 1995, 2 (03) : 121 - 133
  • [44] Sculpting the nervous system: glial control of neuronal development
    Freeman, MR
    CURRENT OPINION IN NEUROBIOLOGY, 2006, 16 (01) : 119 - 125
  • [45] Programmed cell death, apoptosis and nervous system
    Zurak, N
    NEUROLOGIA CROATICA, 1997, 46 (1-2): : 3 - 18
  • [46] Cell death and the developing enteric nervous system
    Chalazonitis, Alcmene
    Gershon, Michael D.
    Greene, Lloyd A.
    NEUROCHEMISTRY INTERNATIONAL, 2012, 61 (06) : 839 - 847
  • [47] One Path to Cell Death in the Nervous System
    Joel Glasgow
    Regino Perez-Polo
    Neurochemical Research, 2000, 25 : 1373 - 1383
  • [48] Cell death and sexual differentiation of the nervous system
    Forger, NG
    NEUROSCIENCE, 2006, 138 (03) : 929 - 938
  • [49] One path to cell death in the nervous system
    Glasgow, J
    Perez-Polo, R
    NEUROCHEMICAL RESEARCH, 2000, 25 (9-10) : 1373 - 1383
  • [50] Cell death in glioblastoma and the central nervous system
    Malone, Kyle
    LaCasse, Eric
    Beug, Shawn T.
    CELLULAR ONCOLOGY, 2025, 48 (02) : 313 - 349